Abstract and Introduction Autonomic Reaction, the Anxiety Response, and Development of Phobic Symptoms Treatment of Self-Injection Anxiety Summary References Autonomic Reaction, the Anxiety ...
WHEN life gave Lina Nielsen lemons, she sprinted straight to the Olympics. The 28-year-old was diagnosed with multiple sclerosis at 17 years old, leaving her terrified of disability. Doctors gave ...
Under the terms of the agreement, TG Therapeutics obtains non-exclusive research, clinical and commercial rights to use MaxCyte’s Flow Electroporation ® technology and ExPERT™ platform. In return, ...
Bleakley Financial Group LLC purchased a new stake in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund purchased 8,140 shares of the ...
The Floodlight MS app, used to track disease progression in people with multiple sclerosis, has been deemed cost-effective in ...
Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with MS in those ...
Mark Abel, a staff member at Herefordshire and Worcestershire Health and Care NHS Trust secured bronze in the British Indoor ...
Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).
Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk ...
Multiple sclerosis may lead to mild short-term memory loss that can affect your ability to recall information. Lifestyle changes could help you manage symptoms. Multiple sclerosis (MS) is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback